|
Volumn 19, Issue 2, 2001, Pages 144-147
|
Helicobacter pylori treatment: A role for probiotics?
|
Author keywords
Helicobacter pylori; Lactobacillus; Probiotics
|
Indexed keywords
ANTIBIOTIC AGENT;
PROBIOTIC AGENT;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG INDICATION;
DRUG USE;
ERADICATION THERAPY;
GRAM NEGATIVE INFECTION;
HELICOBACTER PYLORI;
HUMAN;
LACTOBACILLUS;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
SUPPLEMENTATION;
ANTI-BACTERIAL AGENTS;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
PATIENT COMPLIANCE;
PROBIOTICS;
|
EID: 0034846597
PISSN: 02572753
EISSN: None
Source Type: Journal
DOI: 10.1159/000050669 Document Type: Review |
Times cited : (31)
|
References (17)
|